Methylphenidate treatment (Q34626119)

3 August 2017

1 reference

title

Methylphenidate treatment (English)

1 reference

3 August 2017

Peter Weber

1 reference

3 August 2017

Jürg Lütschg

series ordinal

1 reference

3 August 2017

publication date

1 April 2002

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

261-266

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

3 August 2017

1 reference

7 January 2021

Attention deficit hyperactivity disorder: a disease or a symptom complex?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

The use of psychostimulants in the pediatric patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

The neurodevelopmental price of survival in children with malignant brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Methylphenidate therapy improves cognition, mood, and function of brain tumor patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Neuropsychological patterns in pediatric epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Medication-induced seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Adverse response to methylphenidate in combination with valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Efficacy and specificity of pharmacological therapies for behavioral disorders in persons with mental retardation.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Effects and noneffects of methylphenidate in children with mental retardation and ADHD

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: laboratory effects

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Efficacy of methylphenidate and behavioral intervention on classroom behavior in children with ADHD and mental retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Separate and combined effects of methylphenidate and a behavioral intervention on disruptive behavior in children with mental retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

A controlled trial of stimulant medication in children with the fragile X syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Adverse side effects of methylphenidate among mentally retarded children with ADHD

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Four-year follow-up of children with low intelligence and ADHD

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

A double-blind controlled study of methylphenidate treatment in closed head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Methylphenidate effect on attention deficit in the acutely brain-injured adult

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Methylphenidate treatment following ablation-induced hemiplegia in rat: experience during drug action alters effects on recovery of function

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

The use of methylphenidate in paediatric traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Psychopharmacologic treatment of acquired attention disorders in children with brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Twelve year outcomes following bacterial meningitis: further evidence for persisting effects

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

Long term neurological outcome of herpes encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

A randomized, double-blind, placebo-controlled study of methylphenidate in patients with organic amnesia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900408-8

7 January 2021

10.1016/S0887-8994(01)00408-8

Identifiers

DOI

1 reference

3 August 2017

1 reference